Showing results (11-20 of 168) with videos related to

Sort By:
Pageof 17
Expert Opinion on Biological Therapy|April 17, 2013
Hematopoietic progenitor cells transplantation for recurrent or refractory Hodgkin's lymphomaTiziana Moscato, Roberta Fedele, Giuseppe Messina, et al.
Expert Opinion on Biological Therapy|September 23, 2014
High-dose chemotherapy for germ cell tumors: do we have a model?Andrea Necchi, Francesco Lanza, Giovanni Rosti, et al.
Expert Opinion on Pharmacotherapy|May 14, 2014
Role of new drugs incorporated into consolidation and maintenance therapy in transplant-eligible multiple myeloma patientsMassimo Gentile, Ernesto Vigna, Anna G Recchia, et al.
International Journal of Molecular Sciences|January 21, 2023
Do CAR-T and Allogeneic Stem Cell Transplant Both Have a Place in Lymphoid Neoplasms?Massimo Martino, Filippo Antonio Canale, Virginia Naso, et al.
Journal of Immunology Research|January 21, 2016
Clinical Options in Relapsed or Refractory Hodgkin Lymphoma: An Updated ReviewRoberta Fedele, Massimo Martino, Anna Grazia Recchia, et al.
Cancers|December 11, 2025
Harnessing Venetoclax in NPM1-Mutated AML: A Path to Sustained Remission and BeyondMatteo Molica, Claudia Simio, Laura De Fazio, et al.
Expert Opinion on Investigational Drugs|March 22, 2016
Sorafenib for the treatment of multiple myelomaMassimo Gentile, Massimo Martino, Anna Grazia Recchia, et al.
Expert Opinion on Biological Therapy|March 27, 2012
Long-term safety of granulocyte colony-stimulating factor in normal donors: is it all clear?Massimo Martino, Roberta Fedele, Elisabetta Massara, et al.
International Journal of Molecular Sciences|March 6, 2021
A Review of Clinical Outcomes of CAR T-Cell Therapies for B-Acute Lymphoblastic LeukemiaMassimo Martino, Caterina Alati, Filippo Antonio Canale, et al.
Pageof 17